‐New program, the largest of its kind, provides private lab space for innovative growth-stage biotech companies at state-of-the-art Kendall Square site -

NORTHBROOK, Ill. and CAMBRIDGE, Mass., March 5, 2024 /PRNewswire/ -- LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, and Astellas Pharma US, Inc. (President: Mark Reisenauer, "Astellas") today announced the LabCentral 238 Diamond Ticket award. The Diamond Ticket is the largest lab space award of its kind in the industry and provides an innovative, growth-stage biotech company with a $500,000 credit for private lab space at LabCentral 238, one of the newest facilities in the LabCentral network in the heart of Kendall Square. Interested companies can review program details and apply online before the April 5, 2024 deadline.